Home › Funds › KEATING INVESTMENT COUNSELORS INC › GSK

KEATING INVESTMENT COUNSELORS INC position in GSK

GSK PLC · Health Care

KEATING INVESTMENT COUNSELORS INC reported holding 166,303 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$8.0M, representing 2.10% of its reported portfolio and ranking #12 among its reported holdings. KEATING INVESTMENT COUNSELORS INC has disclosed GSK holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)166.30K sh
Reported value held$8.01M
Portfolio Weight2.10%
First reportedQ4 2024
Last changeHold
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How KEATING INVESTMENT COUNSELORS INC's GSK position evolved

KEATING INVESTMENT COUNSELORS INC first disclosed a stake in GSK in Q4 2024 at 163,605 shares (US$5.5M). The position peaked in Q1 2026 at 175,168 shares, worth US$9.7M. Across 8 filings, KEATING INVESTMENT COUNSELORS INC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 166,303 shares valued at US$8.0M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 163.60K $5.53M New
Q1 2025 188.81K $7.31M Add
Q2 2025 186.80K $7.17M Reduce
Q3 2025 179.53K $7.75M Reduce
Q4 2025 180.11K $8.83M Hold
Q1 2026 175.17K $9.67M Reduce
Q2 2026 166.82K $8.74M Reduce
Q3 2026 166.30K $8.01M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has KEATING INVESTMENT COUNSELORS INC held GSK?

KEATING INVESTMENT COUNSELORS INC has disclosed GSK holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is KEATING INVESTMENT COUNSELORS INC's current position in GSK?

As of Q3 2026, KEATING INVESTMENT COUNSELORS INC holds 166.30K shares of GSK (GSK PLC), valued at $8.01M, representing 2.10% of its reported portfolio and ranking #12.

Has KEATING INVESTMENT COUNSELORS INC been buying or selling GSK?

In the latest 13F filing (Q3 2026), KEATING INVESTMENT COUNSELORS INC held unchanged its position in GSK. The position peaked in Q1 2026 at 175.17K shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.